U.S. Biopharma Plastics Market Size & Outlook, 2022-2030

The biopharma plastics market in the United States is expected to reach a projected revenue of US$ 1,103.9 million by 2030. A compound annual growth rate of 11.7% is expected of the United States biopharma plastics market from 2023 to 2030.
Revenue, 2022 (US$M)
$455.7
Forecast, 2030 (US$M)
$1,103.9
CAGR, 2023 - 2030
11.7%
Report Coverage
U.S.

U.S. biopharma plastics market highlights

  • The U.S. biopharma plastics market generated a revenue of USD 455.7 million in 2022 and is expected to reach USD 1,103.9 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 11.7% from 2023 to 2030.
  • In terms of segment, polyvinyl chloride (pvc) was the largest revenue generating polymer type in 2022.
  • Polypropylene (PP) is the most lucrative polymer type segment registering the fastest growth during the forecast period.


Biopharma plastics market data book summary

Market revenue in 2022USD 455.7 million
Market revenue in 2030USD 1,103.9 million
Growth rate11.7% (CAGR from 2022 to 2030)
Largest segmentPolyvinyl chloride (pvc)
Fastest growing segmentPolypropylene (PP)
Historical data2019 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPolyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other
Key market players worldwideBasf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI


Other key industry trends

  • In terms of revenue, U.S. accounted for 9.5% of the global biopharma plastics market in 2022.
  • Country-wise, China is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. biopharma plastics market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 1,103.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biopharma Plastics Market Companies

Name Profile # Employees HQ Website

U.S. biopharma plastics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.


Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.81% in 2022. Horizon Databook has segmented the U.S. biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.


Key initiatives such as the Affordable Care Act (ACA) and Medicaid undertaken by the Government of the U.S. have enabled a large percentage of the population of the country to have access to effective and improved healthcare facilities and services.

This has fueled the demand for branded drugs, medical devices, and healthcare services in the U.S., thereby driving the consumption of biopharma plastics in the country for developing disposable medical connectors, syringes, depth filters, etc.

According to the American Cancer Society (ACS), breast cancer is the most common cancer that affects women in the U.S. It usually occurs in middle-aged and old women. The use of hormone therapy for the treatment of menopausal symptoms elevates estrogen levels in women. This is one of the major causes of breast cancer in women.

Reasons to subscribe to U.S. biopharma plastics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. biopharma plastics market databook

  • Our clientele includes a mix of biopharma plastics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. biopharma plastics market size, by polymer type, 2019-2030 (US$M)

U.S. Biopharma Plastics Market Outlook Share, 2022 & 2030 (US$M)

U.S. biopharma plastics market size, by polymer type, 2019-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more